Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune inflammatory disease of the central nervous system, and little is known about its immune mechanism at present. There is a lack of disease-related biomarkers in cerebrospinal fluid except anti-NMDAR antibody, which leads to delayed diagnosis and treatment in some patients. Therefore, there has been an increasing number of studies on related cytokines in recent years to assess whether they can be used as new biomarkers for evaluating disease conditions and assisting diagnosis and treatment. Current studies have shown that some cytokines may be associated with the progression of anti-NMDAR encephalitis, and this article reviews the research advances in such cytokines associated with anti-NMDAR encephalitis.
抗N-甲基-D-天冬氨酸受体（N-methyl-D-aspartate receptor，NMDAR）脑炎为一类中枢神经系统自身免疫炎症性疾病，目前对其免疫机制知之甚少。脑脊液中除抗NMDAR抗体检测外，缺乏与疾病相关标志物，导致部分患者延误诊治。为此，近年针对细胞因子的研究不断增加，旨在评价其是否可作为新型生物标志物对疾病进行评估并协助诊治。现有研究表明部分细胞因子与抗NMDAR脑炎疾病进程可能相关，故该文就抗NMDAR脑炎相关细胞因子研究进展进行综述。.
Keywords: Anti-N-methyl-D-aspartate receptor encephalitis; Biomarker; Child; Cytokine.